Almasry Pharmacy

Donifoxat 80 Mg 30 Tablets

Short Description:
Donifoxat 80 mg 30 tablets contains febuxostat, a xanthine oxidase inhibitor used for long-term management of chronic hyperuricaemia in gout. Taken once daily, it helps lower uric acid levels, reduce gout attacks, and protect joints from urate crystal deposition under medical supervision.

EGP 86

Out of Stock
We'll message you as soon as it's back in stock.
delivery-iconDelivery to governorates within 3-4 working days
refund-iconEasy returns within 14 days
Specifications
SKUISG000926
BrandدونيفوكساتLink Icon
Categories
Medication & Treatments
Color
Luscious Blackberry
Concentrations
80 Mg
Shop by ConcernsGoutLink Icon, HyperuricemiaLink Icon, Joint PainLink Icon, TophiLink Icon
Gender
Neutral
Shop By GoalsGout ManagementLink Icon, Joint ProtectionLink Icon, Uric Acid ManagementLink Icon
Imported Or LocalLocal
Ingredient
Febuxostat
UPC
6223002456871
Product Form
Tablets
Specialty
Clinically Tested
Prescription only
Sub Categories
Gout Medicines
Unit Count
30 Tablets
Warning
Caution in cardiovascular disease
May increase heart rate
Monitor liver function
Use under medical supervision only
About the product›

Donifoxat 80 Mg 30 Tablets

Description:

Donifoxat 80 mg 30 tablets (donifoxate 80 mg 30 f.c. tablets) is a prescription oral medicine containing febuxostat, a xanthine oxidase inhibitor used to lower high uric acid levels in the blood. It is primarily indicated for the long-term management of chronic hyperuricaemia in patients with gout where urate crystal deposition has already occurred, helping to prevent gout flares and complications such as tophi and joint damage. Each film-coated tablet delivers 80 mg of febuxostat for once-daily dosing, providing effective and sustained uric acid control under medical supervision.


Indications:

  • Treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history or presence of gouty arthritis and/or tophus).
  • Long-term management of gout by lowering serum uric acid levels.
  • Helps reduce the frequency and severity of gout attacks over time when used regularly.
  • Prevention of complications related to persistent high uric acid levels, such as joint damage and urate crystal deposits, when used as part of a comprehensive gout management plan.

Active Ingredients / Key Components:

  • Febuxostat – 80 mg per film-coated tablet.
  • Other tablet excipients (film-coating agents, fillers, binders, stabilizers) are present but specific names and concentrations , please check the product leaflet or the manufacturer’s official website.

Dosage & Administration / How to Use:

  • Recommended adult dose: 1 tablet (80 mg) once daily, or as directed by your physician.
  • May be taken with or without food; swallow the tablet whole with a sufficient amount of water, without chewing or crushing.
  • Use regularly every day at the same time to maintain stable uric acid levels and achieve optimal gout control.
  • Your doctor may adjust the dose based on your serum uric acid levels, clinical response, and overall health status.
  • This medicine is not intended for the treatment of acute gout attacks; if an acute flare occurs, follow your doctor’s instructions for additional medications.
  • Do not stop taking Donifoxat without consulting your doctor, even if symptoms improve, as uric acid levels may rise again.
  • If you miss a dose, take it as soon as you remember unless it is almost time for the next dose; do not double the dose to make up for a missed tablet.

Clinical Benefits:

  • Effectively lowers serum uric acid levels by inhibiting xanthine oxidase, the key enzyme responsible for uric acid production.
  • Helps reduce the frequency and intensity of recurrent gout attacks when used as long-term urate-lowering therapy.
  • Supports regression or stabilization of urate deposits (tophi) and helps protect joints from further damage associated with chronic gout.
  • Once-daily oral dosing improves treatment adherence and convenience for patients requiring long-term gout management.

Warnings & Contraindications:

  • Contraindicated in patients with known hypersensitivity to febuxostat or any of the excipients in the formulation.
  • Use with caution in patients with a history of major cardiovascular disease (such as myocardial infarction, stroke, or unstable angina); discuss risks and benefits with your doctor.
  • Use with caution in patients with severe renal or hepatic impairment; dose adjustment or alternative therapy may be required as per physician assessment.
  • Monitor liver function tests periodically during treatment, especially in patients with pre-existing liver disease.
  • Acute gout flares may occur at the start of therapy as uric acid levels change; your doctor may prescribe additional medicines (e.g., NSAIDs or colchicine) to prevent or manage flares.
  • Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding; safety data in pregnancy and lactation are limited.
  • Consult your doctor before use if you are taking other medications, especially azathioprine, mercaptopurine, theophylline, or other drugs that may interact with febuxostat.
  • Not intended to diagnose, treat, cure, or prevent any disease without medical supervision; it is a prescription medicine and must be used under the guidance of a healthcare professional.
  • Keep out of reach of children.
  • Do not exceed the prescribed dose and do not share this medicine with others, even if they have similar symptoms.

Side Effects:
  • Common side effects may include headache, dizziness, nausea, diarrhea, abdominal pain, joint pain, or mild rash.
  • Less common but potentially serious side effects can include severe skin reactions, signs of liver problems (such as dark urine, yellowing of skin or eyes, persistent nausea), or cardiovascular events in at-risk patients.
  • Allergic reactions (such as swelling of the face, lips, tongue, difficulty breathing, or severe skin rash) require immediate medical attention and discontinuation of the medicine.
  • If you experience any unusual, persistent, or severe symptoms while taking Donifoxat, contact your doctor or seek medical help promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.


Specifications:
  • Serving size: 1 tablet.
  • Strength: 80 mg febuxostat per film-coated tablet.
  • Count: 30 tablets per pack.
  • Form: Oral film-coated tablet.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

More fromدونيفوكسات

See More

Product Reviews

Overall Rating
0

Based on 0 reviews

Warning iconYou can add a rating once you purchase the product through the My Orders page

Customer Reviews
No reviews yet
TelegramWhatsApp